M&A Deal Summary

Cancer Diagnostics Acquires Anatech

On June 18, 2021, Cancer Diagnostics acquired medical products company Anatech

Acquisition Highlights
  • This is Cancer Diagnostics’ 1st transaction in the Medical Products sector.
  • This is Cancer Diagnostics’ 1st transaction in the United States.
  • This is Cancer Diagnostics’ 1st transaction in Michigan.

M&A Deal Summary
Date 2021-06-18
Target Anatech
Sector Medical Products
Buyer(s) Cancer Diagnostics
Deal Type Add-on Acquisition

Target

Anatech

Battle Creek, Michigan, United States
Anatech is a developer, manufacturer, and retailer of fixatives, processing, and staining reagents. Anatech is supplying distinctive products for anatomical pathology. Anatech was founded in 1984 and is based in Battle Creek, Michigan.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cancer Diagnostics

Durham, North Carolina, United States
Category Company
Founded 1998
Sector Medical Products
DESCRIPTION

Cancer Diagnostics is a provider of anatomic pathology products that developed the first commercially available 7-dye color system for marking tissue margins and today supplies over 6,000 customers with more than 7,000 products in over 50 countries. Cancer Diagnostics was founded in 1998 and is based in Durham, North Carolina.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Michigan) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal